R.A. Session Ii Taysha Gene Therapies, Inc. (TSHA) insider trading activity

R.A. Session Ii is of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 8.87 Million shares of TSHA, which is worth approximately $16.4 Million. The most recent transaction as insider was on Jul 13, 2023, when has been sold 5,344 shares (Common Stock) at a price of $0.7 per share, resulting in proceeds of $3,740. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.87M

0% 3M change

0% 12M change

Total Value Held $16.4 Million

R.A. Session II Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 13 2023	SELL Open market or private sale	$3,740 $0.7 p/Share	5,344 Reduced 0.06%	8,871,747 Common Stock
Jul 12 2023	SELL Open market or private sale	$57,174 $0.71 p/Share	80,528 Reduced 0.9%	8,877,091 Common Stock
Jun 23 2023	SELL Open market or private sale	$12,670 $0.7 p/Share	18,100 Reduced 0.2%	8,957,619 Common Stock
Jun 22 2023	SELL Open market or private sale	$7,355 $0.7 p/Share	10,508 Reduced 0.12%	8,975,719 Common Stock
Jun 21 2023	SELL Open market or private sale	$97,273 $0.7 p/Share	138,962 Reduced 1.52%	8,986,227 Common Stock
Jun 20 2023	SELL Open market or private sale	$209,913 $0.71 p/Share	295,653 Reduced 3.14%	9,125,189 Common Stock
Mar 06 2023	BUY Other acquisition or disposition	-	251,296 Added 2.6%	9,420,842 Common Stock
Nov 23 2021	BUY Open market or private purchase	$526,798 $12.39 p/Share	42,518 Added 0.46%	9,190,920 Common Stock

RSI

R.A. Session Ii

Dallas, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Value

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Taysha Gene Therapies, Inc.

Track Activities on TSHA

Account